VRAX
Virax Biolabs Group
$1.32
+$0.12 (+10%)Oct 29, 2026
Key metrics
The numbers that frame VRAX today
- Market cap
- $764.57K
- Gross margin
- 61.9%
- ROIC
- -333.4%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $1.14
- 52wk High
- $21.75
Growth
Revenue and earnings trend for VRAX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VRAX
Is Virax Biolabs Group a good buy?
No. Virax Biolabs Group has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of VRAX?
Virax Biolabs Group's market capitalization is $764.57K.
What is the 52-week high for VRAX stock?
The 52-week high for Virax Biolabs Group is $21.75. The current close of $1.32 is 93.9% below that high.
What is the 52-week low for VRAX stock?
The 52-week low for Virax Biolabs Group is $1.14. The current close of $1.32 is 15.8% above that low.
Does VRAX stock pay dividends?
Virax Biolabs Group does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VRAX?
Virax Biolabs Group's Debt / Equity ratio is 0.06.